Hodgkin's and Non-Hodgkin's Lymphomas

https://doi.org/10.1016/j.rcl.2006.10.006Get rights and content

Section snippets

Hodgkin's disease

The incidence of Hodgkin's disease (HD) is about 4 per 100,000 persons per year, and accounts for less than 1% of all cancers worldwide. New cases of HD in the United States were estimated at 7880 and accounted for 14% of lymphomas [1], [2], [3]. HD has a bimodal incidence curve and occurs more frequently in two separate age groups, the first being young adulthood, the second being in those over 50 years old. About one third of people with HD have systemic symptoms, such as low-grade fever,

Staging

Accurate staging allows minimization of toxic therapies (such as extended field radiation or overly aggressive chemotherapy), thereby decreasing the risk of secondary malignancies, which exceeds 10% in historical series of patients with early-stage HD [40]. Ann Arbor staging is the staging system for lymphoma, both in HD and NHL. It initially was developed for HD, but it has some use in NHL [4].

The staging classification was modified after a 1988 meeting in Cotswold (UK) (Table 2) [41]. The

Assessment of treatment response

Tumor measurements on an axial cross-sectional imaging modality should be made as biperpendicular measurements in the axial plane (ie, the longest axial diameter by the largest perpendicular diameter). Diffuse, ill-defined lesions such as perirenal infiltration in NHL or pulmonary lymphatic spread are not measurable, but should be described [56].

Standardized guidelines for response assessment are important to facilitate interpretation of data and for comparison of the results among various

Summary

This article reviewed the clinical features of HD and NHL, common imaging features, the staging of lymphoma, and the role of FDG-PET in the assessment of patients with lymphoma. The significant changes that have occurred in the diagnosis and management of lymphoma over the past 20 years were emphasized.

First page preview

First page preview
Click to open first page preview

References (63)

  • A.F. Scarsbrook et al.

    Post-transplantation lymphoproliferative disorder: the spectrum of imaging findings

    Clin Radiol

    (2005)
  • A.K. Ng et al.

    Second malignancy after Hodgkin's disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors

    Blood

    (2002)
  • S.C. Kaste et al.

    18F-fluorodeoxyglucose PET/CT in childhood lymphoma

    PET Clinics

    (2006)
  • R. Elstrom et al.

    Utility of FDG-PET scanning in lymphoma by WHO classification

    Blood

    (2003)
  • G. Jerusalem et al.

    Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL)

    Ann Oncol

    (2001)
  • K.P. Beal et al.

    FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases

    Ann Oncol

    (2005)
  • R. Bar-Shalom

    Normal and abnormal patterns of 18F-Fluorodeoxyglucose PET/CT in lymphoma

    PET Clinics

    (2006)
  • D.A. Podoloff et al.

    PET and PET/CT in the management of lymphomas

    PET Clinics

    (2006)
  • E. Even-Sapir et al.

    Fluorine-18 Fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with non-Hodgkin's lymphoma and Hodgkin's disease

    PET Clinics

    (2006)
  • M. Bangerter et al.

    Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography(FDG-PET) for accurate staging of Hodgkin's disease

    Ann Oncol

    (1998)
  • M. Hutchings et al.

    FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin's lymphoma

    Blood

    (2006)
  • M. Hutchings et al.

    Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin's lymphoma

    Ann Oncol

    (2005)
  • C. Schiepers et al.

    PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma

    Eur J Nucl Med Mol Imaging

    (2003)
  • J.M. Connors

    State-of-the-art therapeutics: Hodgkin's lymphoma

    J Clin Oncol

    (2005)
  • A. Sharma et al.

    Patterns of lymphadenopathy in thoracic malignancies

    Radiographics

    (2004)
  • A. Guermazi et al.

    Extranodal Hodgkin's disease: spectrum of disease

    Radiographics

    (2001)
  • L. Sider et al.

    Varied appearance of AIDS-related lymphoma in the chest

    Radiology

    (1989)
  • S. Apter et al.

    Calcification in Lymphoma occurring before therapy: CT features and clinical correlation

    AJR Am J Roentgenol

    (2002)
  • B.D. Cheson

    What is new in lymphoma?

    CA Cancer J Clin

    (2004)
  • S.K. An et al.

    Gastric mucosa-associated lymphoid tissue lymphoma: spectrum of findings at double-contrast gastrointestinal examination with pathologic correlation

    Radiographics

    (2001)
  • J.H. Byun et al.

    CT findings in peripheral T cell lymphoma involving the gastrointestinal tract

    Radiology

    (2003)
  • Cited by (0)

    View full text